MetaCap

Surrozen (SRZN) News

NASDAQ: SRZNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

28.46-2.21 (-7.21%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SRZN news summary

We found 5 recent headlines mentioning Surrozen (SRZN): 1 in the past week and 4 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. SRZN is making an outsized move today, down 7.21% at $28.46, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Surrozen, Inc. Enters Underwriting Agreement for Common Stock Offering of 1,894,540 Shares", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Surrozen headlines

Compare SRZN